Fidasimtamab (Synonyms: IBI-315; BH2950) |
| Catalog No.GC69111 |
Fidasimtamab (IBI-315; BH2950) est un anticorps bispécifique recombinant de type IgG1 humain, capable de cibler simultanément, se lier et inhiber HER2 et PD-1 ainsi que leurs voies de signalisation en aval, tout en reliant les cellules T exprimant PD-1 aux cellules cancéreuses exprimant HER2. Fidasimtamab possède un potentiel d'activité anti-tumorale et immunosuppressive.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2377419-89-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Fidasimtamab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Fidasimtamab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *